(Q51251585)

2 April 2018

title

Antiepileptic property of inhibitors of carbonic anhydrase (English)

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

4 July 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

4 July 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

4 July 2023

author name string

H. Tanimukai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5835875

4 July 2023

M. Inui

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5835875

4 July 2023

S. Hariguchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5835875

4 July 2023

Z. Kaneko

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5835875

4 July 2023

language of work or name

English

0 references

publication date

1 June 1965

1 reference

2 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0006295265902480?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

https://api.elsevier.com/content/article/PII:0006295265902480?httpAccept=text/plain

4 July 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

4 July 2023

published in

Biochemical Pharmacology

1 reference

2 April 2018

volume

14

1 reference

2 April 2018

issue

6

1 reference

2 April 2018

page(s)

961-970

1 reference

2 April 2018

A Long‐term Follow‐up of Acetazolamide (Diamox) in the Treatment of Epilepsy

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

Ethoxzolamide; a new anticonvulsant

4 July 2023

4

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

On the role of the butanesultam derivative Ospolot in the treatment of cerebral epilepsy

4 July 2023

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

[The treatment of cerebral epilepsy with Ospolot.]

4 July 2023

6

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

[On the clinical evaluation of anti-epileptic medications with special reference to Ospolot.]

4 July 2023

7

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

Journal of Pharmacology and Experimental Therapeutics

4 July 2023

10

115

251

Millichap

1955

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

Journal of Pharmacology and Experimental Therapeutics

4 July 2023

11

121

160

Gray

1957

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

N-(4'SULFAMYPHENYL)-BUTANSULTAM(1-4)(OSPOLOT) AS CARBONIC ANHYDRASE INHIBITOR IN THE BRAIN

4 July 2023

12

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

Journal of Pharmacology and Experimental Therapeutics

4 July 2023

16

130

26

Maren

1960

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

Sulphanilamide as a Specific Inhibitor of Carbonic Anhydrase

4 July 2023

17

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

Distribution of carbonic anhydrase in human brain.

4 July 2023

18

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

Journal of Pharmacology and Experimental Therapeutics

4 July 2023

19

139

350

Gray

1963

1 reference

https://api.crossref.org/works/10.1016/0006-2952(65)90248-0

4 July 2023

Identifiers

1 reference

2 April 2018

1 reference

2 April 2018